Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. miRNA Extraction and Expression
2.3. Statistical Analysis
3. Results
3.1. Study Population
3.2. Identification of MDD-Associated miRNAs
3.3. ROC Curves Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Fries, G.R.; Zhang, W.; Benevenuto, D.; Quevedo, J. MicroRNAs in Major Depressive Disorder. In Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders; Guest, P.C., Ed.; Advances in Experimental Medicine and Biology; Springer International Publishing: Cham, Switzerland, 2019; Volume 1118, pp. 175–190. ISBN 978-3-030-05541-7. [Google Scholar]
- Navneet Bain, S.A. Major Depressive Disorder. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK559078/ (accessed on 18 September 2023).
- Marx, W.; Penninx, B.W.J.H.; Solmi, M.; Furukawa, T.A.; Firth, J.; Carvalho, A.F.; Berk, M. Major Depressive Disorder. Nat. Rev. Dis. Primer 2023, 9, 44. [Google Scholar] [CrossRef]
- Otte, C.; Gold, S.M.; Penninx, B.W.; Pariante, C.M.; Etkin, A.; Fava, M.; Mohr, D.C.; Schatzberg, A.F. Major Depressive Disorder. Nat. Rev. Dis. Primer 2016, 2, 16065. [Google Scholar] [CrossRef] [PubMed]
- Chand SP, A.H. Depression. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2024. [Google Scholar]
- Lohoff, F.W. Overview of the Genetics of Major Depressive Disorder. Curr. Psychiatry Rep. 2010, 12, 539–546. [Google Scholar] [CrossRef] [PubMed]
- Enatescu, I.; Kalinovic, R.; Giurgi-Oncu, C.; Poroch, V.; Stratulat, I.S.; Vlad, G.; Neda-Stepan, O.; Simu, M.; Papava, I.; Oancea, R.; et al. Study on the Role of Inflammatory Markers and Type D Personality on Symptom Profiles and Severity in Patients with Major Depressive Disorder. Appl. Sci. 2020, 10, 5615. [Google Scholar] [CrossRef]
- Enatescu, V.-R.; Enatescu, I.; Craina, M.; Gluhovschi, A.; Papava, I.; Romosan, R.; Marian, C.; Oprea, A.; Bernad, E. State and Trait Anxiety as a Psychopathological Phenomenon Correlated with Postpartum Depression in a Romanian Sample: A Pilot Study. J. Psychosom. Obstet. Gynecol. 2014, 35, 55–61. [Google Scholar] [CrossRef]
- Almeida, M.I.; Reis, R.M.; Calin, G.A. MicroRNA History: Discovery, Recent Applications, and next Frontiers. Mutat. Res. Mol. Mech. Mutagen. 2011, 717, 1–8. [Google Scholar] [CrossRef]
- Prodan-Bărbulescu, C.; Şeclăman, E.P.; Enătescu, V.; Faur, I.F.; Ghenciu, L.A.; Tuţac, P.; Paşca, P.; Grigoriţă, L.O. Evaluating the Connec-tion between MicroRNAs and Long Non-Coding RNAs for the Establishment of the Major Depressive Disorder Diagnosis. Biomedicines 2024, 12, 516. [Google Scholar] [CrossRef]
- Brosius, J.; Raabe, C.A. What Is an RNA? A Top Layer for RNA Classification. RNA Biol. 2016, 13, 140–144. [Google Scholar] [CrossRef]
- Santosh, B.; Varshney, A.; Yadava, P.K. Non-coding RNAs: Biological Functions and Applications. Cell Biochem. Funct. 2015, 33, 14–22. [Google Scholar] [CrossRef]
- Yanas, A.; Liu, K.F. RNA Modifications and the Link to Human Disease. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 2019; Volume 626, pp. 133–146. ISBN 978-0-12-818669-5. [Google Scholar]
- Hombach, S.; Kretz, M. Non-Coding RNAs: Classification, Biology and Functioning. In Non-Coding RNAs in Colorectal Cancer; Slaby, O., Calin, G.A., Eds.; Advances in Experimental Medicine and Biology; Springer International Publishing: Cham, Switzerland, 2016; Volume 937, pp. 3–17. ISBN 978-3-319-42057-8. [Google Scholar]
- Agrawal, N.; Dasaradhi, P.V.N.; Mohmmed, A.; Malhotra, P.; Bhatnagar, R.K.; Mukherjee, S.K. RNA Interference: Biology, Mechanism, and Applications. Microbiol. Mol. Biol. Rev. 2003, 67, 657–685. [Google Scholar] [CrossRef] [PubMed]
- MacFarlane, L.-A.; R Murphy, P. MicroRNA: Biogenesis, Function and Role in Cancer. Curr. Genom. 2010, 11, 537–561. [Google Scholar] [CrossRef] [PubMed]
- Mori, M.A.; Ludwig, R.G.; Garcia-Martin, R.; Brandão, B.B.; Kahn, C.R. Extracellular miRNAs: From Biomarkers to Mediators of Physiol-ogy and Disease. Cell Metab. 2019, 30, 656–673. [Google Scholar] [CrossRef] [PubMed]
- Keller, A.; Gröger, L.; Tschernig, T.; Solomon, J.; Laham, O.; Schaum, N.; Wagner, V.; Kern, F.; Schmartz, G.P.; Li, Y.; et al. miRNATis-sueAtlas2: An Update to the Human miRNA Tissue Atlas. Nucleic Acids Res. 2022, 50, D211–D221. [Google Scholar] [CrossRef]
- Serafini, G.; Pompili, M.; Hansen, K.F.; Obrietan, K.; Dwivedi, Y.; Amore, M.; Shomron, N.; Girardi, P. MicroRNAs: Fundamental Regula-tors of Gene Expression in Major Affective Disorders and Suicidal Behavior? Front. Cell. Neurosci. 2013, 7, 208. [Google Scholar] [CrossRef]
- Homorogan, C.; Nitusca, D.; Seclaman, E.; Enatescu, V.; Marian, C. Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators. Life 2021, 11, 1073. [Google Scholar] [CrossRef]
- Wang, H. MicroRNAs, Multiple Sclerosis, and Depression. Int. J. Mol. Sci. 2021, 22, 7802. [Google Scholar] [CrossRef]
- Bian, Q.; Chen, J.; Wu, J.; Ding, F.; Li, X.; Ma, Q.; Zhang, L.; Zou, X.; Chen, J. Bioinformatics Analysis of a TF-miRNA-lncRNA Regulatory Network in Major Depressive Disorder. Psychiatry Res. 2021, 299, 113842. [Google Scholar] [CrossRef] [PubMed]
- Gecys, D.; Dambrauskiene, K.; Simonyte, S.; Patamsyte, V.; Vilkeviciute, A.; Musneckis, A.; Butkute-Sliuoziene, K.; Lesauskaite, V.; Zemaitis, L.; Usaite, D.; et al. Circulating Hsa-Let-7e-5p and Hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders. Dis. Markers 2022, 2022, 3004338. [Google Scholar] [CrossRef]
- Maffioletti, E.; Cattaneo, A.; Rosso, G.; Maina, G.; Maj, C.; Gennarelli, M.; Tardito, D.; Bocchio-Chiavetto, L. Peripheral Whole Blood microRNA Alterations in Major Depression and Bipolar Disorder. J. Affect. Disord. 2016, 200, 250–258. [Google Scholar] [CrossRef]
- Yan, X.; Zeng, D.; Zhu, H.; Zhang, Y.; Shi, Y.; Wu, Y.; Tang, H.; Li, D. MiRNA-532-5p Regulates CUMS-Induced Depression-Like Behaviors and Modulates LPS-Induced Proinflammatory Cytokine Signaling by Targeting STAT3. Neuropsychiatr. Dis. Treat. 2020, 16, 2753–2764. [Google Scholar] [CrossRef] [PubMed]
- Clayton, S.A.; Jones, S.W.; Kurowska-Stolarska, M.; Clark, A.R. The Role of microRNAs in Glucocorticoid Action. J. Biol. Chem. 2018, 293, 1865–1874. [Google Scholar] [CrossRef] [PubMed]
- Dwivedi, Y. Emerging Role of microRNAs in Major Depressive Disorder: Diagnosis and Therapeutic Implications. Dialogues Clin. Neurosci. 2014, 16, 43–61. [Google Scholar] [CrossRef] [PubMed]
- Pinchi, E.; Frati, P.; Arcangeli, M.; Volonnino, G.; Tomassi, R.; Santoro, P.; Cipolloni, L. MicroRNAs: The New Challenge for Traumatic Brain Injury Diagnosis. Curr. Neuropharmacol. 2020, 18, 319–331. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Lv, T.; Jiang, L.; Kong, L.; Yang, J. MicroRNA-29c-3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31. Oncol. Rep. 2020, 43, 953–964. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Frankel, D.; Delecourt, V.; Novoa-Del-Toro, E.-M.; Robin, J.D.; Airault, C.; Bartoli, C.; Carabalona, A.; Perrin, S.; Mazaleyrat, K.; De Sandre-Giovannoli, A.; et al. miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence. Iscience 2022, 25, 103757. [Google Scholar] [CrossRef]
Variables | Patients with MDD (n = 10) | Healthy Controls (n = 8) |
---|---|---|
Age in years (median) | 43.7 | 41.75 |
Male/Female | 3/7 | 2/6 |
Number | miRNA ID | Fold Regulation | p-Value |
---|---|---|---|
BM 1 | hsa-mir-29c-3p | 3.72 | 0.017 |
BM 2 | hsa-mir-200a-3p | 2.08 | 0.027 |
BM 3 | hsa-mir-18b-5p | 4.28 | 0.036 |
BM 4 | hsa-mir-335-5p | 3.12 | 0.037 |
BM 5 | hsa-mir-15b-5p | 3.38 | 0.038 |
BM 6 | hsa-mir-320c | 3.5 | 0.039 |
BM 7 | hsa-mir-7-5p | 3.32 | 0.040 |
BM 8 | hsa-mir-532-3p | 7.45 | 0.040 |
BM 9 | hsa-mir-376a-3p | 2.45 | 0.042 |
BM 10 | hsa-mir-532-5p | 15.67 | 0.043 |
BM 11 | hsa-mir-136-3p | −2.22 | 0.045 |
BM 12 | hsa-mir-339-5p | 4.87 | 0.045 |
BM 13 | hsa-mir-19a-3p | 2.74 | 0.045 |
BM 14 | hsa-mir-33a-5p | 2.68 | 0.047 |
BM 15 | hsa-mir-483-5p | 3.84 | 0.048 |
BM/miRNA | t | p-Value | |
---|---|---|---|
One-Sided p | Two-Sided p | ||
BM1 hsa-mir-29c-3p | 2.612 | 0.009 | 0.019 |
BM2 hsa-mir-200a-3p | 0.724 | 0.240 | 0.479 |
BM3 hsa-mir-18b-5 | 0.947 | 0.179 | 0.358 |
BM4 hsa-mir-335-5p | 0.844 | 0.205 | 0.411 |
BM5 hsa-mir-15b-5p | 1.726 | 0.035 | 0.071 |
BM6 hsa-mir-320c | 1.936 | 0.042 | 0.084 |
BM7 hsa-mir-7-5p | 2.560 | 0.010 | 0.021 |
BM8 hsa-mir-532-3p | 1.276 | 0.110 | 0.220 |
BM9 hsa-mir-376a-3p | 2.579 | 0.010 | 0.020 |
BM10 hsa-mir-532-5p | 2.242 | 0.020 | 0.040 |
BM11 hsa-mir-136-3p | −2.520 | 0.011 | 0.023 |
BM12 hsa-mir-339-5p | 3.225 | 0.003 | 0.005 |
BM 13 hsa-mir-19a-3p | 1.099 | 0.144 | 0.288 |
BM 14 hsa-mir-33a-5p | 1.594 | 0.065 | 0.131 |
BM15 hsa-mir-483-5p | 2.107 | 0.026 | 0.051 |
Marker | Area ± Std. Error | 95% CI |
---|---|---|
BM1 | 0.83 ± 0.10 | (0.64–1.03) |
BM5 | 0.28 ± 0.12 | (0.04–0.53) |
BM6 | 0.72 ± 0.13 | (0.50–1.00) |
BM7 | 0.73 ± 0.13 | (0.48–0.98) |
BM9 | 0.81 ± 0.10 | (0.61–1.00) |
BM10 | 0.83 ± 0.09 | (0.64–1.00) |
BM11 | 0.78 ± 0.11 | (0.56–1.00) |
BM12 | 0.83 ± 0.09 | (0.64–1.00) |
BM15 | 0.75 ± 0.13 | (0.50–1.00) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Prodan-Bărbulescu, C.; Ghenciu, L.A.; Şeclăman, E.; Bujor, G.C.; Enătescu, V.; Danila, A.-I.; Dăescu, E.; Rosu, L.M.; Faur, I.F.; Tuţac, P.; et al. Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective. Curr. Issues Mol. Biol. 2024, 46, 10846-10853. https://doi.org/10.3390/cimb46100644
Prodan-Bărbulescu C, Ghenciu LA, Şeclăman E, Bujor GC, Enătescu V, Danila A-I, Dăescu E, Rosu LM, Faur IF, Tuţac P, et al. Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective. Current Issues in Molecular Biology. 2024; 46(10):10846-10853. https://doi.org/10.3390/cimb46100644
Chicago/Turabian StyleProdan-Bărbulescu, Cătălin, Laura Andreea Ghenciu, Edward Şeclăman, Georgeta Cristiana Bujor, Virgil Enătescu, Alexandra-Ioana Danila, Ecaterina Dăescu, Luminioara Maria Rosu, Ionuţ Flaviu Faur, Paul Tuţac, and et al. 2024. "Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective" Current Issues in Molecular Biology 46, no. 10: 10846-10853. https://doi.org/10.3390/cimb46100644